• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. PDS II POLYDIOXANONE SUTURE UNKNOWN PRODUCT; SUTURE, SURGICAL, ABSORBABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. PDS II POLYDIOXANONE SUTURE UNKNOWN PRODUCT; SUTURE, SURGICAL, ABSORBABLE Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pneumonia (2011); Sepsis (2067)
Event Date 12/29/2020
Event Type  Death  
Event Description
Title: the multidisciplinary management of recurrent tracheoesophageal fistula after esophageal atresia: experience with 135 cases from a tertiary center.This retrospective study aims to report a retrospective seven-year review of our experience in the management of recurrent tracheoesophageal fistula (rtef), and compare the clinical outcomes before and after the application of the multidisciplinary (mdt) approach.Between june 2012 and december 2019, 135 patients with recurrent tracheoesophageal fistula (rtef) were treated at the department of pediatric general surgery, xin- hua hospital of shanghai jiao tong university school of medicine, shanghai, china.All patients included in the studies had recurrent tracheoesophageal fistula (rtef) after repair of esophageal atresia and tracheoesophageal fistula (eatef).All patients were divided into two groups based on the different strategies adopted in the treatment: the pre-multidisciplinary (mdt) group ( n = 35) with 22 males with gestational age 39.0 (34.0¿41.0 weeks ) and age at recurrent tracheoesophageal fistula (rtef) repair 7.5 (2.4¿45.6 months) and the post-multidisciplinary (mdt) group ( n = 100) with 67 males with gestational age 39.1 (31.0¿41.4 weeks) and age at recurrent tracheoesophageal fistula (rtef) repair 7.7 (2.3¿59.7 months).During surgical repair of recurrent tracheoesophageal fistula (rtef),for the patients who had multi-site fistulas and had undergone more than three operations for tef, an esophageal replacement was considered.We used 5¿0 absorbable monofilament sutures (pds-ii, ethicon ) for esophageal/tracheal repair to minimize inflammation and foreign body reactions.The median follow-up was 25.8 months (range, 6.0¿84.5 months).Reported complications included: (n=25) had anastomotic stenosis (as), and all of them were cured by serial balloon dilation.(n=24) developed anastomotic leak (al), and 26 of these cases were resolved by conservative treatment, while two other patients underwent a second reoperation and had an uneventful recovery.(n=8) second recurrence of the repaired tracheoesophageal fistula (tef) was noted.Among them, we identified anastomotic leak (al).In 10 patients before the development of the second recurrence of tracheoesophageal fistula (tef).The remaining two patients with a second recurrence of tef had an uneventful recovery without anastomotic leak (al) and anastomotic- stenosis (as) after original surgical repair for recurrent tracheoesophageal fistula (rtef).Except for the one who refused reoperation, the remaining 11 patients with second recurrence of tracheoesophageal fistula (tef) received reoperations, and eight of them were cured.(n=3) developed a third recur- recurrence of tracheoesophageal fistula (tef).Esophageal replacement (colonic interposition) was performed in one patient at six months after the second reoperation- and led to a satisfied outcome.One patient was cured by a third revisional surgical repair for tracheoesophageal fistula (tef).The remaining patient had a fourth recurrence of tracheoesophageal fistula (tef) combined with multiple esophageal-right upper bronchus fistulas, and segmental resection of esophagus and partial right upper lobectomy were performed successfully to close the tracheoesophageal fistula (tef).(n=4) subglottic stenosis with weaning failure.Granulation formation in the vocal cord and the subglottic area was identified by laryngoscopy and all were cured by endoscopic therapy.(n=2) tracheal stenosis and granulation formation was found at the distal end of the endotracheal tube and was removed under rigid bronchoscopy.(n=1) the patient had weaning failure, and bronchoscopy revealed lower tracheal stenosis caused by granulation tissue.The parents decided to transfer the patient to another hospital, and the patient died from severe pneumonia and septicemia after endoscopic tracheal stent therapy.(n=23) pathological gastroesophageal reflux (ger).Endoscopic evaluation was recommended, but it was only performed in two patients and confirmed gastroesophageal reflux (ger).With esophagitis.Eighteen of them were relieved by conservative treatment.The remaining five patients underwent nissen fundoplication, and none of them experienced dysphagia or vomiting after fundoplication.It was concluded ,that the multidisciplinary- (mdt) approach by fostering coordination of surgical, medical, radiological, and nutritional management is beneficial in the management of recurrent tracheoesophageal fistula (rtef) and leads to a satisfactory outcome.
 
Manufacturer Narrative
Product complaint # (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc, or its employees that the report constitutes an admission that the product, ethicon inc, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.Does the surgeon believe that any of the ethicon products involved caused and/or contributed to the post-operative complications/death described in the article? which specific ethicon products have been used during the procedures (product code, lot number)? does the surgeon believe there was any deficiency with any of the ethicon products used in this procedure? if so, please provide details.Were the cases discussed in this article previously reported to ethicon? if yes, please provide a complaint reference number.Patient demographics? would the journal author / physician like to speak with ethicon medical safety and engineering via scheduled conference call regarding the product involved in this event? this report is related to a journal article; therefore, no product will be returned for analysis and the batch history records cannot be reviewed as the lot number has not been provided.(b)(4).The single complaint was reported with multiple events.There are no additional details regarding the additional events.Related events captured via 2210968-2022-08757.Citation: journal of pediatric surgery 56 (2021) 1918¿1925.Https://doi.Org/10.1016/j.Jpedsurg.2020.12.019.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PDS II POLYDIOXANONE SUTURE UNKNOWN PRODUCT
Type of Device
SUTURE, SURGICAL, ABSORBABLE
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
ETHICON INC.
Manufacturer Contact
elba bello
1000 route 202
raritan, NJ 08869
9083863534
MDR Report Key15670461
MDR Text Key302394164
Report Number2210968-2022-08758
Device Sequence Number1
Product Code NEW
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
N18331
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional,User Facility
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 11/03/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/25/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received10/28/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Death;
-
-